Home> Products> chronic bronchitis and emphysema relief

{ "products": [ { "_id": "6905fe704704b5ad3ff33652", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Salmeterol and Fluticasone Propionate Inhalation IP ", "description": "Salmeterol and Fluticasone Propionate Inhalation IP is a combination medication widely used for the management and long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). This dual-acting inhalation therapy combines two powerful active ingredients — Salmeterol, a long-acting bronchodilator, and Fluticasone Propionate, a corticosteroid. Together, they work synergistically to ease breathing difficulties, control inflammation, and prevent respiratory flare-ups.\n\nIn India, respiratory diseases such as asthma and COPD affect millions of people, especially due to pollution, smoking, and changing environmental conditions. For these individuals, Salmeterol and Fluticasone Propionate Inhalation IP serves as a cornerstone therapy that offers reliable control of symptoms and improves overall lung function.\n\nComposition and Mechanism of Action\n\nThis inhalation medication contains:\n\nSalmeterol (50 mcg) – a long-acting β₂-adrenergic receptor agonist (LABA) that relaxes airway muscles, allowing air to flow more freely into the lungs.\n\nFluticasone Propionate (250 mcg or 500 mcg) – a potent corticosteroid that helps reduce inflammation, swelling, and mucus production in the airways.\n\nWhen inhaled, Salmeterol provides prolonged bronchodilation, maintaining open airways for up to 12 hours, while Fluticasone acts directly on lung tissues to minimize inflammatory responses. This dual mechanism ensures both immediate relief and long-term control of respiratory symptoms.\n\nUses of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Asthma\n\nThis combination is one of the most prescribed maintenance therapies for asthma management. It helps reduce the frequency and severity of asthma attacks, improves breathing capacity, and enables patients to lead a more active lifestyle.\n\n2. Chronic Obstructive Pulmonary Disease (COPD)\n\nIt is also indicated for COPD, including chronic bronchitis and emphysema. In these conditions, it helps relieve breathlessness, persistent cough, and wheezing, thereby improving lung efficiency and quality of life.\n\n3. Prevention of Asthma Exacerbations\n\nRegular use of this inhalation helps prevent sudden asthma flare-ups triggered by allergens, cold weather, or exercise.\n\n4. Improvement of Lung Function\n\nBy consistently controlling inflammation and relaxing airway muscles, the medication enhances FEV₁ (Forced Expiratory Volume), a measure of how efficiently a patient can exhale.\n\nKey Benefits of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Dual Therapeutic Action\n\nThe combination of a bronchodilator (Salmeterol) and an anti-inflammatory (Fluticasone) provides comprehensive control over both the causes and symptoms of respiratory conditions.\n\n2. Long-Lasting Relief\n\nWith its long-acting formulation, patients experience up to 12 hours of relief, reducing the need for frequent dosing and ensuring steady symptom control throughout the day or night.\n3. Prevention of Asthma and COPD Attacks\nRegular use helps minimize acute exacerbations, reducing hospital visits, emergency interventions, and dependency on quick-relief inhalers.\n4. Improved Breathing Comfort\n\nBy opening up constricted airways and controlling inflammation, it allows for easier breathing, better oxygen exchange, and improved stamina in daily activities.\n5. Enhanced Quality of Life\nPatients on regular inhalation therapy report fewer night-time symptoms, improved sleep, and better physical endurance, allowing them to enjoy an active, productive life.\n6. Targeted Lung Delivery\n\nAs an inhalation-based therapy, it directly delivers medication to the lungs where it’s most needed, minimizing systemic exposure and potential side effects.\n\nHow to Use\n\nShake the inhaler well before use to ensure even distribution of medicine.\n\nExhale fully and then inhale deeply through the mouthpiece while pressing down the canister to release one dose.\n\nHold your breath for a few seconds to allow the medicine to reach deep into the lungs.\n\nRinse your mouth after use to reduce the risk of fungal infections like oral thrush.\n\nPatients are advised to use the inhaler regularly at the same time each day for best results. It is not meant for sudden asthma attacks — a separate rescue inhaler should be kept for emergency relief.\n\nPossible Side Effects\n\nLike any medication, Salmeterol and Fluticasone Propionate Inhalation IP may cause mild to moderate side effects, though not everyone experiences them. Common side effects include:\n\n1. Oral and Throat Irritation\n\nDryness, irritation, or hoarseness of the throat may occur. Rinsing the mouth after use helps minimize this.\n\n2. Oral Thrush (Candidiasis)\n\nProlonged corticosteroid use can increase the risk of fungal infections in the mouth. Maintaining oral hygiene is essential.\n\n3. Headache or Dizziness\n\nSome users may experience mild headaches or lightheadedness, which typically subside over time.\n\n4. Muscle or Joint Pain\n\nOccasional mild muscle cramps or joint discomfort may occur, especially in long-term use.\n\n5. Palpitations or Tremors\n\nIn rare cases, Salmeterol may cause a slight increase in heart rate or mild tremors, particularly when the dose is higher than recommended.\n\n6. Cough or Respiratory Discomfort\n\nMild coughing or a temporary feeling of breath tightness may occur immediately after inhalation but usually passes quickly.\n\nIf any side effects persist or worsen, it is advisable to consult a healthcare professional immediately.\n\nPrecautions and Warnings\n\nNot for sudden asthma attacks — this inhaler should be used only for maintenance therapy.\n\nPregnant or breastfeeding women should use it only after medical advice.\n\nDo not exceed the prescribed dose as overuse may increase the risk of cardiovascular side effects.\n\nPatients with heart disease, hypertension, or diabetes should inform their doctor before starting treatment.\n\nAlways store the inhaler in a cool, dry place, away from direct sunlight and moisture.\n\nConclusion\n\nSalmeterol and Fluticasone Propionate Inhalation IP is a clinically proven, reliable treatment option for individuals suffering from chronic respiratory conditions like asthma and COPD. By combining the bronchodilatory power of Salmeterol with the anti-inflammatory efficacy of Fluticasone Propionate, it delivers long-term symptom control, improves lung function, and enhances quality of life.\n\nWhen used consistently and correctly under medical supervision, this inhalation therapy not only helps manage respiratory symptoms but also reduces the frequency of exacerbations and hospitalizations. For patients seeking dependable relief and sustained respiratory health, Salmeterol and Fluticasone Propionate Inhalation IP remains one of the most trusted and effective therapies available today.", "price": 442.0, "discountamount": 132.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2194, "imageuri": "https://productimages.withfloats.com/actual/6905fe746e096b327485136e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6905fe746e096b327485136e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-01T12:34:56.205Z", "updatedon": "2026-03-14T08:22:24.626Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/salmeterol-and-fluticasone-propionate-inhalation-ip-/2194", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "AIRFLOW 50 INH", "category": "ASTHMA RANGE", "tags": [ "Salmeterol and Fluticasone Propionate Inhalation IP", "asthma and chronic obstructive pulmonary disease (COPD)", "Fluticasone Propionate", "air to flow" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863d2854c1970de3d96ebcd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "fluticasone furoate and vilanterol powder for inhalation", "description": "FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness.\n\nThis powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term control of asthma symptoms such as wheezing, coughing, and breathlessness\n\nMaintenance treatment of COPD, including chronic bronchitis and emphysema\n\nPrevention of asthma exacerbations and hospitalizations\n\nImprovement in lung function and quality of life in chronic respiratory patients\n\nRegular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations.\n\nFluticasone Furoate and Vilanterol Powder for Inhalation Side Effects\nWhile generally well-tolerated, some users may experience mild to moderate side effects including:\n\nHeadache\n\nThroat irritation\n\nHoarseness of voice\n\nOral thrush (fungal infection in the mouth)\n\nCough or upper respiratory tract infections\n\nIncreased heart rate or palpitations\n\nMuscle cramps or tremors\n\nRare allergic reactions like rash, itching, or swelling\n\nTo minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation.\n\nPrecautions Before Using FLUTICATONE VILO 100\nDo not use it to treat sudden asthma attacks; it is not a rescue inhaler.\n\nInform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems.\n\nUse with caution in pregnancy and breastfeeding; consult your physician.\n\nRegular monitoring of lung function and adrenal activity is recommended during long-term use.\n\nChildren and adolescents may require special dose adjustments under medical supervision.\n\nDrug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol?\nSeveral medications may interact with this combination and alter its effectiveness or increase the risk of side effects:\n\nBeta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol\n\nKetoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects\n\nDiuretics: May increase the risk of hypokalemia when used with vilanterol\n\nOther corticosteroids: Concurrent use may enhance systemic corticosteroid side effects\n\nMAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects\n\nAlways inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100.\n\nConclusion\nFLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.", "price": 525.0, "discountamount": 158.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "combination ensures", "improved quality", "medications supplements", "drugs interact", "mouth cough", "reduce dependency", "synthetic corticosteroid", "asthma attacks", "asthma exacerbations", "asthma symptoms", "persistent asthma", "vilanterol powder", "controls inflammation", "reduces inflammation", "vilanterol ketoconazole", "lungs vilanterol", "vilanterol 25 mcg", "essential component", "bronchodilating effect", "antiinflammatory strength", "herbal products", "healthcare provider", "tricyclic antidepressants", "corticosteroids concurrent", "blood raising", "bronchodilatory effect", "adrenal activity", "breastfeeding consult", "liver problems", "fluticatone vilo 100", "oral thrush", "rash itching", "experience mild", "generally welltolerated", "emphysema prevention", "wheezing coughing", "prescription medication", "airflow obstruction", "constriction making", "chest tightness", "wheezing shortness", "inhalation precautions", "rescue inhalers", "hospitalizations improvement", "prevent flareups", "improves breathing", "fluticasone furoate", "chronic bronchitis", "lung function", "relaxing muscles", "rescue inhaler inform", "adolescents fluticasone furoate", "manage chronic symptoms", "inhalation fluticasone furoate", "lung function improvement", "effective longterm control", "breathing fewer flareups", "inhalation longterm control", "relaxing airway muscles", "inhalation side effects", "longterm maintenance treatment", "provide longterm relief", "chronic respiratory care", "consistent symptom control", "amplify cardiovascular effects", "side effects diuretics", "strong cyp3a4 inhibitors", "side effects betablockers", "physician regular monitoring", "palpitations muscle cramps", "moderate side effects", "breathlessness maintenance treatment", "acute bronchospasm relief", "fastacting treatment choice" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2139, "imageuri": "https://productimages.withfloats.com/actual/6863d28eeb66715cb5e18de8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6863d28eeb66715cb5e18de8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:20:21.253Z", "updatedon": "2026-03-14T08:43:27.599Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//fluticasone-furoate-and-vilanterol-powder-for-inhalation/2139", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLUTICATONE VILO 100", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation", "Chronic Obstructive Pulmonary Disease (COPD).", "relaxing airway muscles.", "shortness of breath.", "chest tightness.", "lung function improvement." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a685f3a5315456e18559082", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Acebrophylline and Erdosteine Tablets", "description": "Acebrophylline and Erdosteine Tablets are a clinically trusted combination used in the management of chronic respiratory disorders associated with excessive mucus production, airway inflammation, and breathing difficulties. This dual-action formulation combines the bronchodilator and anti-inflammatory properties of Acebrophylline with the mucolytic and antioxidant benefits of Erdosteine, making it an effective treatment option for patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, and other mucus-related respiratory conditions.\n\nAt [Your Company Name], we manufacture and supply premium-quality Acebrophylline and Erdosteine Tablets that comply with WHO-GMP standards and international pharmaceutical quality guidelines. Our formulations are trusted by healthcare professionals, hospitals, distributors, and pharmaceutical companies seeking reliable respiratory medicines.\n\nComposition\nEach film-coated tablet typically contains:\n\nAcebrophylline – 200 mg\nErdosteine – 300 mg\nComposition can be customized based on customer requirements and regulatory approvals.\n\nHow Acebrophylline and Erdosteine Tablets Work\nThe combination provides comprehensive respiratory support through complementary mechanisms.\n\nAcebrophylline\nAcebrophylline acts as a bronchodilator and anti-inflammatory agent. It helps relax bronchial muscles, widens the airways, improves airflow, and reduces inflammation, making breathing easier for patients with chronic respiratory diseases.\n\nErdosteine\nErdosteine is a powerful mucolytic agent that reduces the thickness and stickiness of mucus. It facilitates easier expectoration, reduces coughing, and provides antioxidant protection against airway damage caused by inflammation.\n\nTogether, these ingredients improve lung function, reduce respiratory symptoms, and enhance patient comfort.\n\nKey Benefits of Acebrophylline and Erdosteine Tablets\nHelps improve breathing by relaxing bronchial muscles\nEffectively reduces thick mucus accumulation\nSupports easier mucus clearance from the lungs\nReduces chronic cough and chest congestion\nHelps manage COPD and chronic bronchitis symptoms\nProvides antioxidant protection to respiratory tissues\nImproves oxygen exchange and lung function\nEnhances quality of life in patients with chronic respiratory disorders\nSuitable for long-term respiratory disease management under medical supervision\nMedical Uses of Acebrophylline and Erdosteine Tablets\nHealthcare professionals commonly prescribe Acebrophylline and Erdosteine Tablets for:\n\nChronic Obstructive Pulmonary Disease (COPD)\nChronic Bronchitis\nBronchial Asthma\nRespiratory Tract Infections with Excessive Mucus\nChronic Productive Cough\nAirway Inflammation\nBronchiectasis\nSmoking-related Respiratory Conditions\nThese tablets should always be used under the supervision of a qualified healthcare professional.\n\nAdvantages of the Acebrophylline and Erdosteine Combination\nThe combination therapy offers several clinical advantages over single-drug treatment.\n\nDual Mechanism of Action\nIt simultaneously opens the airways while reducing mucus thickness, providing comprehensive respiratory relief.\n\nImproved Lung Function\nPatients experience better airflow and enhanced breathing comfort due to bronchodilation and mucus clearance.\n\nReduced Frequency of Exacerbations\nRegular use, as prescribed, may help decrease episodes of worsening respiratory symptoms in chronic lung diseases.\n\nBetter Patient Compliance\nA fixed-dose combination simplifies treatment by reducing the need for multiple medications.\n\nRecommended Dosage\nThe dosage of Acebrophylline and Erdosteine Tablets should be determined by a registered healthcare provider based on the patient's age, condition, and medical history.\n\nGeneral recommendations include:\n\nTake the tablet after meals with water.\nSwallow whole without crushing or chewing.\nFollow the prescribed duration of therapy.\nDo not exceed the recommended dose.\nPossible Side Effects\nLike all medicines, Acebrophylline and Erdosteine Tablets may cause side effects in some individuals.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nHeadache\nDizziness\nMild diarrhea\nDry mouth\nGastric irritation\nSeek immediate medical attention if severe allergic reactions, breathing difficulty, or persistent adverse effects occur.\n\nPrecautions\nBefore using Acebrophylline and Erdosteine Tablets, patients should inform their healthcare provider if they have:\n\nLiver disease\nKidney impairment\nGastric ulcer\nHeart disease\nPregnancy or breastfeeding\nKnown allergy to methylxanthines or Erdosteine\nAvoid self-medication and always follow professional medical advice.\n\nStorage Instructions\nStore below 25°C in a cool and dry place.\nProtect from direct sunlight and moisture.\nKeep out of reach of children.\nDo not use after the expiry date.\nWhy Choose Our Acebrophylline and Erdosteine Tablets?\nWe are committed to delivering pharmaceutical products that meet international quality standards.\n\nOur advantages include:\n\nWHO-GMP Certified Manufacturing\nISO Certified Production Facilities\nStringent Quality Control\nDCGI-Compliant Manufacturing\nCompetitive Pricing\nBulk Supply Capability\nThird-Party Manufacturing Services\nPrivate Label Packaging\nTimely Global Deliveries\nCustom Packaging Solutions\nWe serve pharmaceutical distributors, hospitals, government tenders, exporters, wholesalers, and healthcare institutions worldwide.\n\nFrequently Asked Questions (FAQs)\n1. What are Acebrophylline and Erdosteine Tablets used for?\nAcebrophylline and Erdosteine Tablets are primarily used to treat respiratory conditions such as COPD, chronic bronchitis, asthma, and other diseases associated with excessive mucus production and airway obstruction.\n\n2. How do Acebrophylline and Erdosteine Tablets work?\nAcebrophylline relaxes the bronchial muscles and reduces inflammation, while Erdosteine breaks down thick mucus, making it easier to remove from the lungs.\n\n3. Can Acebrophylline and Erdosteine Tablets treat chronic cough?\nYes. These tablets help relieve chronic productive cough by reducing mucus viscosity and improving airway clearance when prescribed by a healthcare professional.\n\n4. Are Acebrophylline and Erdosteine Tablets safe for long-term use?\nThey may be prescribed for long-term management of chronic respiratory diseases, but treatment duration should always be determined by a physician.\n\n5. Can these tablets be used for asthma?\nYes. Doctors may prescribe Acebrophylline and Erdosteine Tablets as part of asthma management when mucus accumulation and airway inflammation are significant.\n\n6. Do Acebrophylline and Erdosteine Tablets have side effects?\nMost side effects are mild and temporary, including nausea, headache, dizziness, stomach upset, and dry mouth. Serious reactions are uncommon but require immediate medical attention.\n\n7. Should Acebrophylline and Erdosteine Tablets be taken before or after food?\nThey are generally recommended after meals to reduce the risk of stomach irritation. Follow your doctor's advice regarding dosage and timing.\n\n8. Can smokers use Acebrophylline and Erdosteine Tablets?\nYes. Physicians often prescribe them to smokers suffering from chronic bronchitis, COPD, or mucus-related respiratory disorders.\n\n9. Are Acebrophylline and Erdosteine Tablets available for third-party manufacturing?\nYes. We offer third-party manufacturing, private labeling, customized packaging, and bulk pharmaceutical supply for domestic and international markets.\n\n10. Why buy Acebrophylline and Erdosteine Tablets from us?\nOur products are manufactured in WHO-GMP-certified facilities using premium-quality raw materials, strict quality control processes, competitive pricing, and reliable global distribution, making us a trusted pharmaceutical manufacturing partner.\n\nThis version is optimized for buyer intent, includes keyword-rich headings and FAQs designed for Google Search and voice search, and naturally targets the primary keyword “Acebrophylline and Erdosteine Tablets” throughout the content without excessive keyword stuffing.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2487, "imageuri": "https://productimages.withfloats.com/actual/6a685f3db435445dbdc3d469.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a685f3db435445dbdc3d469.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T07:50:18.551Z", "updatedon": "2026-07-28T07:50:18.551Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//acebrophylline-and-erdosteine-tablets/2487", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIPHYLLIN ERDO", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a03166b3678f86a626aca60", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glycopyrrolate formoterol fumarate and budesonide inhalation", "description": "Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nWhen patients and healthcare providers search for a reliable inhalation therapy for chronic respiratory conditions, Glycopyrrolate + Formoterol Fumarate + Budesonide inhalation stands out as a modern triple-combination treatment designed to support long-term breathing management. This combination is commonly prescribed in patients requiring advanced maintenance therapy for chronic airway obstruction and inflammation.\nThe three active ingredients work together to help open the airways, reduce inflammation, and improve overall lung function. Triple-combination inhalation therapy is widely used in chronic respiratory management and is commonly prescribed for adults needing long-term control of airway symptoms. \nWhat is Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation?\nThis inhalation contains three clinically proven medicines:\n1. Glycopyrrolate\nGlycopyrrolate helps relax airway muscles by blocking muscarinic receptors. This action keeps air passages open for easier breathing.\n2. Formoterol Fumarate\nFormoterol is a long-acting bronchodilator that helps maintain airway relaxation for extended periods.\n3. Budesonide\nBudesonide reduces airway inflammation, swelling, and irritation, helping lower flare-ups in chronic respiratory disease.\nTogether, these three medicines create a comprehensive treatment option for respiratory maintenance therapy. \nKey Buyer Benefits of This Inhalation\nHealthcare professionals and procurement teams often choose this inhalation because of its multiple benefits:\nSuperior Triple Action\nInstead of prescribing multiple inhalers, this triple combination provides three therapeutic actions in one inhalation device.\nImproved Lung Function\nPatients may experience better airflow and improved breathing comfort with regular prescribed use.\nReduced Respiratory Flare-Ups\nClinical use shows that triple therapy can help reduce worsening episodes in chronic airway disease. \nBetter Patient Compliance\nA single inhaler may improve convenience and adherence to treatment plans.\nCommon Uses of Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nThis inhalation is commonly prescribed for:\n\n\nChronic Obstructive Pulmonary Disease (COPD)\n\n\nChronic bronchitis\n\n\nAirflow limitation disorders\n\n\nLong-term respiratory maintenance therapy\n\n\nPhysician-directed asthma maintenance in appropriate patients\n\n\nThis medicine is for maintenance treatment and is not intended for immediate relief of sudden breathing attacks. \nHow Does This Triple Combination Work?\nEach component contributes differently:\nGlycopyrrolate reduces airway tightening.\nFormoterol Fumarate keeps air passages open for longer periods.\nBudesonide controls airway inflammation.\nThis combined mechanism helps support easier breathing and better respiratory stability.\nWhy Buyers Choose This Product\nHospitals, distributors, pharmacies, and healthcare procurement teams often look for products that offer:\n\n\nHigh therapeutic value\n\n\nReliable respiratory support\n\n\nEasy inhalation administration\n\n\nReduced need for multiple inhalers\n\n\nStrong physician acceptance\n\n\nBecause this product combines anti-inflammatory and bronchodilator benefits, it remains a preferred respiratory care option.\nDosage and Administration\nThe exact dosage should always be prescribed by a healthcare professional.\nTypical maintenance inhalation regimens are taken twice daily depending on formulation and clinical need. Patients should rinse their mouth after use to help reduce local side effects. \nImportant Usage Tips\n\n\nShake inhaler before use\n\n\nUse exactly as prescribed\n\n\nDo not exceed recommended doses\n\n\nPrime inhaler if instructed\n\n\nStore in a cool and dry place\n\n\nPossible Side Effects\nLike all prescription medicines, some users may experience side effects such as:\n\n\nDry mouth\n\n\nThroat irritation\n\n\nHoarseness\n\n\nMild cough\n\n\nHeadache\n\n\nOral fungal infection\n\n\nFast heartbeat in some patients\n\n\nMost effects are manageable under medical supervision. \nSafety Precautions\nBefore using this inhalation, patients should inform their doctor if they have:\n\n\nHeart disease\n\n\nHigh blood pressure\n\n\nDiabetes\n\n\nThyroid disorders\n\n\nKidney problems\n\n\nLiver disease\n\n\nGlaucoma\n\n\nPregnant or breastfeeding patients should use it only under medical supervision.\nPackaging and Commercial Availability\nThis product is generally available in metered-dose inhaler packaging suitable for:\n\n\nHospitals\n\n\nMedical distributors\n\n\nExport buyers\n\n\nRetail pharmacies\n\n\nRespiratory specialty clinics\n\n\nBulk procurement options may be available depending on manufacturer and supply chain requirements.\nWhy This Inhalation is a Smart Healthcare Purchase\nFor medical buyers and respiratory specialists, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation offers:\n\n\nTriple mechanism support\n\n\nTrusted respiratory treatment profile\n\n\nStrong prescription demand\n\n\nGrowing market acceptance\n\n\nLong-term patient care utility\n\n\nConclusion\nIf you are searching for an advanced respiratory maintenance solution, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation delivers comprehensive airway support through bronchodilation and anti-inflammatory action. Whether for hospital procurement, pharmacy distribution, or physician prescribing needs, this triple-combination inhalation remains a high-demand therapeutic option in respiratory medicine.\n", "price": 885.0, "discountamount": 266.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2417, "imageuri": "https://productimages.withfloats.com/actual/6a03166ee67a7c906d87cf8d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a03166ee67a7c906d87cf8d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-12T12:00:43.79Z", "updatedon": "2026-06-04T07:57:03.191Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glycopyrrolate-formoterol-fumarate-and-budesonide-inhalation/2417", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDEPRESS PLUS INH", "category": "ASTHMARANGE", "tags": [ "glycopyrrolate formoterol fumarate and budesonide inhalation", "buy budesonide glycopyrrolate formoterol fumarate", "budesonide glycopyrrolate formoterol fumarate", "glycopyrrolate formoterol fumarate", "Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation", "Buy Glycopyrrolate Formoterol Budesonide Inhaler Online", "Triple Combination Inhaler for COPD Treatment", "Asthma Treatment Inhaler with Budesonide and Formoterol", "Budesonide Formoterol Glycopyrrolate Inhalation Therapy", "Prescription Inhaler for COPD and Asthma Management", "Glycopyrrolate Formoterol Budesonide Inhaler Product Image", "Best Triple Therapy Inhaler for Breathing Disorders", "Budesonide Glycopyrrolate Formoterol Inhaler for Lung Care", "Budesonide, glycopyrrolate, formoterol brand name", "glycopyrrolate formoterol fumarate and budesonide inhalation in hindi", "glycopyrrolate formoterol fumarate and budesonide inhalation price", "glycopyrrolate formoterol fumarate and budesonide inhalation price in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69942f823b20a66d9dcf9458", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "description": "GLYCOPRESS INDUS™ is a modern dual bronchodilator therapy formulated with Indacaterol Maleate and Glycopyrronium Bromide, designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This advanced inhalation formulation combines two complementary mechanisms of action to deliver sustained airway relaxation, improved lung function, and enhanced breathing comfort.\n\nCOPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and episodes of breathlessness. Effective management requires consistent bronchodilation to keep the airways open and reduce daily symptoms. GLYCOPRESS INDUS™ addresses this need through a once-daily maintenance approach that targets airway narrowing through dual pharmacological pathways.\n\nManufactured under strict quality standards, GLYCOPRESS INDUS™ ensures reliable dosing, stability, and optimal pulmonary delivery when used with the recommended inhalation device. It is intended for regular use and not for the treatment of sudden breathing emergencies.\n\nComposition and Mechanism of Action\n\nGLYCOPRESS INDUS™ combines two long-acting bronchodilators:\n\n1. Indacaterol Maleate (Long-Acting Beta2-Agonist – LABA)\n\nIndacaterol stimulates beta2-adrenergic receptors located in the smooth muscles of the airways. Activation of these receptors causes the muscles to relax, resulting in bronchodilation. This effect:\n\nReduces airway resistance\n\nImproves airflow\n\nDecreases breathlessness\n\nSupports 24-hour bronchodilation\n\nIndacaterol is known for its rapid onset and prolonged duration of action, making it effective for once-daily therapy.\n\n2. Glycopyrronium Bromide (Long-Acting Muscarinic Antagonist – LAMA)\n\nGlycopyrronium blocks muscarinic receptors in the bronchial smooth muscles. These receptors normally respond to acetylcholine, which causes airway constriction. By inhibiting this response, glycopyrronium:\n\nPrevents bronchospasm\n\nReduces airway tightening\n\nPromotes sustained airway relaxation\n\nDual-Action Advantage\n\nThe combination of LABA and LAMA in GLYCOPRESS INDUS™ provides enhanced bronchodilation compared to either agent alone. While indacaterol actively relaxes airway muscles, glycopyrronium prevents them from tightening. This complementary action ensures comprehensive and sustained airway management.\n\nIndications and Uses\n\nGLYCOPRESS INDUS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nChronic bronchitis management\n\nEmphysema management\n\nLong-term airflow limitation therapy\n\nIt is important to understand that GLYCOPRESS INDUS™:\n\nIs not a rescue inhaler\n\nShould not be used for sudden acute bronchospasm\n\nIs not intended for primary asthma treatment unless prescribed by a physician\n\nPatients should always keep a short-acting bronchodilator available for emergency relief.\n\nKey Benefits of GLYCOPRESS INDUS™\n1. Once-Daily Dosing Convenience\n\nGLYCOPRESS INDUS™ is formulated for once-daily administration, improving adherence and simplifying treatment routines.\n\n2. Dual Bronchodilation for Superior Airway Control\n\nThe LABA + LAMA combination provides broader and more effective airway relaxation compared to single-agent therapy.\n\n3. Rapid Onset with Sustained Effect\n\nIndacaterol provides quick bronchodilation, while glycopyrronium maintains airway openness for up to 24 hours.\n\n4. Improved Lung Function\n\nRegular use can enhance lung performance parameters, such as improved airflow measurements and reduced air trapping.\n\n5. Reduced Breathlessness\n\nPatients may experience decreased shortness of breath during physical activities, leading to greater independence.\n\n6. Lower Frequency of COPD Exacerbations\n\nConsistent airway maintenance can help reduce the likelihood of flare-ups and hospital visits.\n\n7. Enhanced Quality of Life\n\nBetter breathing control contributes to improved sleep, increased exercise tolerance, and overall well-being.\n\nDosage and Administration\n\nGLYCOPRESS INDUS™ should be used exactly as prescribed by a healthcare professional.\n\nGeneral Administration Guidelines:\n\nUse once daily at the same time each day.\n\nInhale using the provided inhalation device.\n\nDo not swallow capsules (if capsule-based system).\n\nDo not exceed the recommended dose.\n\nFollow inhaler technique instructions carefully.\n\nProper inhalation technique is essential for effective drug delivery. Healthcare providers should demonstrate correct usage during initial prescription.\n\nPossible Side Effects\n\nWhile GLYCOPRESS INDUS™ is generally well tolerated, some individuals may experience side effects.\n\nCommon Side Effects\n\nDry mouth\n\nCough\n\nThroat irritation\n\nHeadache\n\nNasal congestion\n\nMild tremor\n\nDizziness\n\nThese symptoms are often mild and may diminish with continued use.\n\nCardiovascular Effects\n\nDue to the beta2-agonist component (indacaterol), some patients may experience:\n\nIncreased heart rate\n\nPalpitations\n\nMild fluctuations in blood pressure\n\nPatients with pre-existing heart conditions should consult their physician before starting therapy.\n\nAnticholinergic Effects (from Glycopyrronium)\n\nDifficulty urinating\n\nBlurred vision\n\nWorsening of narrow-angle glaucoma\n\nIndividuals with urinary retention or glaucoma should use caution.\n\nRare but Serious Reactions\n\nParadoxical bronchospasm (worsening breathing immediately after inhalation)\n\nSevere allergic reactions\n\nSignificant cardiac rhythm disturbances\n\nImmediate medical attention should be sought if severe reactions occur.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS INDUS™, inform your healthcare provider if you have:\n\nCardiovascular disease\n\nArrhythmias\n\nHypertension\n\nHyperthyroidism\n\nDiabetes\n\nSeizure disorders\n\nGlaucoma\n\nProstate enlargement\n\nKidney impairment\n\nDrug Interactions\n\nCaution is required when using:\n\nOther long-acting beta2-agonists\n\nOther anticholinergic medications\n\nBeta-blockers\n\nDiuretics\n\nCertain antidepressants (e.g., MAO inhibitors)\n\nAlways provide a complete list of medications and supplements to your healthcare provider.\n\nWho Should Use GLYCOPRESS INDUS™?\n\nGLYCOPRESS INDUS™ is ideal for:\n\nAdults with moderate to severe COPD\n\nPatients not adequately controlled on single bronchodilator therapy\n\nIndividuals seeking a once-daily maintenance inhaler\n\nPatients requiring dual bronchodilation for improved symptom control\n\nIt is not typically recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nIntegrating GLYCOPRESS INDUS™ into COPD Management\n\nFor optimal results, GLYCOPRESS INDUS™ should be part of a comprehensive COPD management plan that includes:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular physical activity\n\nBalanced nutrition\n\nScheduled medical follow-ups\n\nAdherence to therapy and routine monitoring significantly improve long-term outcomes.\n\nStorage Instructions\n\nStore at room temperature\n\nProtect from moisture and direct sunlight\n\nKeep in original packaging until use\n\nKeep out of reach of children\nConclusion\nGLYCOPRESS INDUS™ (Indacaterol Maleate + Glycopyrronium Bromide) is a powerful dual bronchodilator designed to provide sustained airway control in individuals living with chronic obstructive pulmonary disease. By combining a long-acting beta2-agonist and a long-acting muscarinic antagonist, it offers comprehensive bronchodilation through two complementary pathways.", "price": 703.0, "discountamount": 211.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2308, "imageuri": "https://productimages.withfloats.com/actual/69942f8410196f5f212c916f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69942f8410196f5f212c916f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-17T09:06:10.4Z", "updatedon": "2026-04-08T08:59:59.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//fdc-of-indacaterol-maleate-and-glycopyrronium-bromide-inhalation-powder/2308", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLYCOPRESS INDUS", "category": "ASTHMARANGE", "tags": [ "indacaterol maleate", "fdc of indacaterol maleate uses", "fdc of indacaterol maleate uses in hindi", "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "indacaterol maleate and glycopyrronium bromide", "indacaterol maleate glycopyrronium bromide price", "fdc of indacaterol maleate" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693410b5de5d3e57a934024e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Levosalbutamol Respiratory Solution 0.31 mg ", "description": "THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg delivers targeted bronchodilation through nebulization, making it an essential therapy for asthma, COPD, and acute bronchospasm in adults and children. This low-dose formulation of the active R-isomer of salbutamol relaxes airway muscles swiftly, improving airflow and reducing symptoms like wheezing and shortness of breath. Ideal for patients needing gentle yet effective respiratory support, it ensures deep lung delivery via fine mist for optimal efficacy.​\n\nKey Uses of THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg\nTHEO-SLO LEVO LD addresses obstructive airway diseases by directly targeting bronchial constriction. Primary indications include acute asthma attacks, chronic bronchitis, emphysema, and exercise-induced symptoms, where it restores normal breathing patterns efficiently.​\n\nAsthma Management: Relieves wheezing, chest tightness, and breathlessness during flare-ups or as maintenance therapy.​\n\nCOPD Support: Eases airflow restriction in chronic bronchitis and emphysema, enhancing daily activities.​\n\nAcute Bronchospasm: Provides fast intervention for triggers like allergens, infections, or pollutants.​\n\nExercise-Induced Relief: Prevents airway narrowing during physical exertion.​\n\nPediatric and Elderly Use: Nebulizer-friendly for young children or those unable to use inhalers.​\n\nAdministered via nebulizer, dilute as prescribed (typically 0.31 mg in 2-3 ml saline) for 5-10 minute sessions, 2-4 times daily based on severity.​\n\nKey Benefits of THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg\nAs the purified R-isomer, Levosalbutamol in THEO-SLO LEVO LD offers higher potency and fewer side effects than racemic salbutamol, with rapid onset within minutes. Its nebulized form penetrates deeper into lungs, making it superior for severe cases or coordination-challenged patients.​\n\nQuick Bronchodilation: Relaxes smooth muscles to open airways, improving oxygen intake immediately.​\n\nEnhanced Tolerability: Lower cardiac stimulation reduces tachycardia risk compared to standard albuterol.​\n\nPatient-Friendly Delivery: Mist form suits infants, seniors, and acute distress without coordination needs.​\n\nSymptom Control: Decreases cough frequency, wheezing intensity, and respiratory distress for better quality of life.​\n\nLonger Relief Duration: Sustained action supports maintenance therapy alongside controllers like steroids.​\n\nClinical use shows improved lung function (FEV1 increase by 20-30%) and reduced hospitalization rates in responsive patients.​\n\nPotential Side Effects and Precautions for THEO-SLO LEVO LD\nTHEO-SLO LEVO LD remains well-tolerated at 0.31 mg, with most effects mild and transient. Monitor during initial use, especially in cardiac patients.​\n\nCommon Mild Effects: Tremors, nervousness, headache, or mild palpitations resolving quickly.​\n\nLess Frequent: Dry mouth, throat irritation, or muscle cramps from overuse.​\n\nRare Serious: Hypokalemia, paradoxical bronchospasm, or severe tachycardia—seek immediate care.​\n\nAvoid in hypersensitivity, uncontrolled arrhythmias, or with beta-blockers. Use cautiously in pregnancy (Category C), hyperthyroidism, diabetes, or hypertension; taper during weaning.​\n\nDosage Guidelines and Best Practices\nFor adults/children >12 years: 0.31-0.63 mg nebulized 3-4 times daily; children 2-12 years: half dose. Always dilute, use fresh solution, and clean nebulizer post-use. Combine with anti-inflammatories for chronic management; do not exceed recommended frequency.​\n\nConclusion: Breathe Easier with THEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg\nTHEO-SLO LEVO LD Levosalbutamol Respiratory Solution 0.31 mg transforms respiratory care by offering swift, reliable bronchodilation for asthma, COPD, and bronchospasm across age groups. Its selective action, nebulizer compatibility, and safety profile make it a cornerstone for symptom relief and lung health preservation. Consult healthcare providers for integrated therapy to achieve optimal breathing freedom and prevent exacerbations.​\n\n", "price": 306.0, "discountamount": 92.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2235, "imageuri": "https://productimages.withfloats.com/actual/693410b81213a99c808c771d.png", "tileimageuri": "https://productimages.withfloats.com/tile/693410b81213a99c808c771d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-06T11:17:09.692Z", "updatedon": "2026-04-06T12:53:19.949Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//levosalbutamol-respiratory-solution-0-31-mg-/2235", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THEO-SLO LEVO LD", "category": "ASTHMA RANGE", "tags": [ "Levosalbutamol Respiratory Solution 0.31 mg", "nebulization", "improving airflow", "respiratory support", "therapy for asthma", "chronic obstructive pulmonary disease (COPD)", "levosalbutamol respiratory solution 0.31 mg uses", "levosalbutamol respiratory solution 0.31 mg dosage", "levosalbutamol respiratory solution 0.31 mg for nebulization", "levosalbutamol respiratory solution 0.31 mg for nebulization", "levosalbutamol respiratory solution 0.31 mg for children", "levosalbutamol respiratory solution 0.31 mg for asthma", "levosalbutamol respiratory solution 0.31 mg side effects", "levosalbutamol respiratory solution 0.31 mg price in india", "levosalbutamol 0.31 mg nebulizer solution uses", "what is levosalbutamol respiratory solution 0.31 mg", "how does levosalbutamol respiratory solution work", "levosalbutamol 0.31 mg nebulization benefits", "levosalbutamol respiratory solution for cough and cold", "best levosalbutamol respiratory solution 0.31 mg", "levosalbutamol respiratory solution 0.31 mg manufacturer", "levosalbutamol respiratory solution 0.31 mg supplier india", "buy levosalbutamol respiratory solution 0.31 mg online", "levosalbutamol 0.31 mg nebulizer dose for infants", "levosalbutamol respiratory solution 0.31 mg hospital use", "evosalbutamol nebulizer solution for pediatric asthma" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6912fc8c470ec71b0ac87646", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "mometasone furoate formoterol fumarate inhaler", "description": "Mometasone Furoate and Formoterol Fumarate Inhaler is a combination respiratory medication formulated to provide effective and long-lasting control of asthma and chronic obstructive pulmonary disease (COPD). It combines two powerful active ingredients — Mometasone Furoate, a corticosteroid (anti-inflammatory), and Formoterol Fumarate, a long-acting bronchodilator (LABA). Together, these components help patients breathe easier by reducing airway inflammation and relaxing the muscles of the airways.\n\nThis dual-action inhaler is designed for maintenance therapy rather than immediate relief of acute symptoms. By targeting both inflammation and bronchial constriction, it provides a comprehensive approach to long-term respiratory management. Each inhalation delivers a precise dose to ensure consistent therapeutic results and improved lung function.\n\nMometasone Furoate and Formoterol Fumarate Inhaler is ideal for individuals who experience persistent asthma symptoms or airflow obstruction due to COPD, despite using single-ingredient inhalers.\n\nUses and Therapeutic Indications\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler is prescribed for the following respiratory conditions:\n\nAsthma (Bronchial Asthma):\n\nUsed for the long-term control and prevention of symptoms such as wheezing, breathlessness, and chest tightness.\n\nHelps reduce inflammation and airway hyperreactivity to prevent asthma attacks.\n\nChronic Obstructive Pulmonary Disease (COPD):\n\nHelps manage chronic bronchitis and emphysema by improving airflow and reducing airway inflammation.\n\nMaintenance Therapy:\n\nProvides ongoing treatment for patients whose symptoms are not adequately controlled by inhaled corticosteroids or bronchodilators alone.\n\nThis inhaler is not meant for emergency relief during sudden asthma attacks but rather as a daily maintenance therapy to control symptoms and prevent exacerbations.\n\nKey Benefits\n\nDual Mechanism of Action:\nCombines the anti-inflammatory power of Mometasone Furoate with the bronchodilating action of Formoterol Fumarate, offering complete respiratory control in one inhaler.\n\nReduces Airway Inflammation:\nMometasone Furoate suppresses the body’s inflammatory response, helping reduce swelling, mucus buildup, and irritation in the airways.\n\nLong-Lasting Bronchodilation:\nFormoterol provides fast and sustained relaxation of airway muscles, improving airflow and making breathing easier for up to 12 hours.\n\nImproves Lung Function:\nRegular use enhances pulmonary capacity, allowing patients to perform daily activities without breathing difficulty.\n\nFewer Asthma Exacerbations:\nReduces the frequency and severity of asthma attacks and flare-ups associated with COPD.\n\nConvenient Combination Therapy:\nProvides the benefits of two medications in a single device, improving compliance and simplifying treatment routines.\n\nBetter Symptom Control:\nProven to decrease wheezing, coughing, and nighttime symptoms, leading to better sleep and overall quality of life.\n\nRapid Onset of Action:\nFormoterol acts within minutes to ease breathing while Mometasone works continuously to maintain long-term inflammation control.\n\nPossible Side Effects\n\nWhile the Mometasone Furoate and Formoterol Fumarate Inhaler is well tolerated, some individuals may experience mild to moderate side effects, especially during the early phase of therapy. These include:\n\nThroat Irritation or Dryness\n\nHoarseness or Voice Changes\n\nHeadache or Dizziness\n\nCough or Upper Respiratory Tract Infections\n\nMuscle Cramps or Tremors\n\nPalpitations (Fast or Irregular Heartbeat)\n\nNausea or Mild Stomach Upset\n\nOral Thrush (Fungal Infection in the Mouth or Throat) – often preventable by rinsing the mouth with water after inhalation.\n\nPrecautions:\n\nThis inhaler is not a rescue medication; a short-acting bronchodilator should be kept on hand for sudden breathing attacks.\n\nRegular use is essential for best results — do not stop suddenly without consulting a doctor.\n\nPatients with heart conditions, hypertension, thyroid disorders, diabetes, or osteoporosis should use this medicine under medical supervision.\n\nAlways rinse the mouth after use to prevent fungal infections.\n\nConclusion\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler represents a modern, evidence-based approach to managing chronic respiratory conditions such as asthma and COPD. By combining a corticosteroid (to reduce airway inflammation) with a long-acting bronchodilator (to open the airways), it provides effective, dual-action relief that lasts throughout the day.\n\nRegular use of this inhaler helps improve breathing capacity, reduces symptom frequency, and enhances quality of life for individuals struggling with chronic lung diseases. It not only helps patients achieve better control over their respiratory symptoms but also reduces the need for emergency interventions and hospitalizations.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2199, "imageuri": "https://productimages.withfloats.com/actual/6912fc8e6447ec42b9808956.png", "tileimageuri": "https://productimages.withfloats.com/tile/6912fc8e6447ec42b9808956.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-11T09:06:20.511Z", "updatedon": "2026-03-14T08:49:38.354Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mometasone-furoate-formoterol-fumarate-inhaler/2199", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MONTASENSE F INH", "category": "ASTHMA RANGE", "tags": [ "Mometasone Furoate and Formoterol Fumarate Inhaler", "respiratory medication", "chronic obstructive pulmonary disease (COPD)", "muscles of the airways.", "respiratory control in one inhaler", "Mometasone Furoate Formoterol Fumarate inhaler for asthma treatment", "Mometasone Furoate Formoterol Fumarate dosage guide", "Mometasone Furoate Formoterol Fumarate inhaler side effects", "Best time to use Mometasone Furoate Formoterol Fumarate inhaler", "Buy Mometasone Furoate Formoterol Fumarate inhaler online", "Mometasone Furoate Formoterol Fumarate inhaler price per unit", "Where to purchase Mometasone Furoate Formoterol Fumarate inhaler", "Mometasone Furoate Formoterol Fumarate inhaler buy at the best price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcad9fed2e6fda11c49da5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate IP 6 mcg & Budesonide IP 200 mcg", "description": "Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) often require a dual-acting therapy that can provide both rapid symptom relief and long-term inflammation control.\nBUDESHINE F 200 is a scientifically advanced inhalation therapy that combines Formoterol Fumarate (a long-acting bronchodilator) and Budesonide (a corticosteroid). This dual formulation is designed to target the root causes of breathing difficulties—airway inflammation and bronchoconstriction—providing patients with improved lung function, reduced symptoms, and better quality of life.\nComposition\nEach dose of BUDESHINE F 200 contains:\nFormoterol Fumarate – A long-acting β2-adrenergic agonist (LABA)\nBudesonide 200 mcg – An inhaled corticosteroid (ICS)\nMechanism of Action\nFormoterol Fumarate\nActs as a long-acting bronchodilator.\nStimulates β2-receptors in the airway smooth muscle, leading to relaxation and widening of bronchial passages.\nProvides rapid onset (within minutes) and sustained action for up to 12 hours, ensuring long-lasting relief from breathlessness and wheezing.\nBudesonide\nA potent corticosteroid with powerful anti-inflammatory properties.\nReduces swelling, irritation, and mucus production in the airways.\nHelps prevent asthma attacks and COPD exacerbations when used regularly.\n Together, this combination ensures symptom relief, prevention of flare-ups, and long-term disease control.\nTherapeutic Indications\nBUDESHINE F 200 is prescribed for:\nAsthma – maintenance therapy for patients requiring both a bronchodilator and corticosteroid.\nChronic Obstructive Pulmonary Disease (COPD) – including chronic bronchitis and emphysema.\nPrevention of Exercise-Induced Bronchospasm (when used as maintenance therapy).", "price": 195.0, "discountamount": 58.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2186, "imageuri": "https://productimages.withfloats.com/actual/68fccd49565ed08cb9c69f49.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fccd49565ed08cb9c69f49.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T10:59:43.46Z", "updatedon": "2026-03-14T08:46:14.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-200-mcg/2186", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 200 CAP", "category": "ASTHMA RANGE", "tags": [ "formoterol budesonide 6mcg 200mcg inhaler uses", "formoterol fumarate budesonide 200 mcg inhaler dosage guide", "formoterol budesonide inhaler for asthma relief", "formoterol budesonide 6/200 mcg inhaler side effects", "how to use formoterol fumarate 6mcg budesonide 200mcg inhaler", "formoterol budesonide 6/200mcg inhaler for COPD treatment", "formoterol fumarate budesonide 6/200mcg inhaler precautions", "buy formoterol budesonide 6/200 mcg inhaler online", "formoterol fumarate budesonide inhaler price in india", "formoterol budesonide 6/200 mcg inhaler for asthma control", "formoterol fumarate budesonide inhaler benefits for breathing", "formoterol budesonide inhaler dosage and side effects guide" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6880ce12b566f87e592f9db9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " Etophylline, Theophylline and Salbutamol Tablets", "description": "SLO THEO ES Tablets is a powerful triple-action bronchodilator formulation designed to provide relief from respiratory conditions such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders. This unique blend of Etophylline, Theophylline, and Salbutamol works synergistically to relax the bronchial muscles, improve airflow, and reduce the severity and frequency of bronchospasms.\n\nBy combining etophylline and theophylline tablets with salbutamol, SLO THEO ES delivers a comprehensive respiratory support mechanism that not only opens up the airways but also helps in reducing inflammation and enhancing oxygen intake in the lungs. It is formulated to offer rapid relief while also supporting long-term control of respiratory symptoms.\n\nWhat is SLO THEO ES?\nSLO THEO ES is a combination medication containing etophylline 231 mg, theophylline 69 mg, and salbutamol 4 mg. Each of these components serves a specific function in easing breathing difficulties:\nEtophylline is a derivative of theophylline and acts as a bronchodilator with additional anti-inflammatory effects.\nTheophylline is a methylxanthine that relaxes the smooth muscles of the airways and improves diaphragm function.\nSalbutamol is a β2-adrenergic agonist that quickly relieves bronchospasm by relaxing airway muscles.\n\nThis combination makes SLO THEO ES highly effective for individuals who require both immediate and sustained bronchodilation.\nUses of SLO THEO ES Tablets:\nSLO THEO ES is prescribed for a range of chronic and acute respiratory conditions. It is especially beneficial in:\nBronchial asthma\nChronic Obstructive Pulmonary Disease (COPD)\nEmphysema\nChronic bronchitis\n\nAllergic bronchitis\n\nWheezing and breathlessness due to bronchospasm\n\nOther obstructive airway diseases\n\nThe etophylline and theophylline tablets in the formulation work on the central and peripheral pathways of the respiratory system, while salbutamol provides rapid symptom relief during acute attacks.\n\nSide Effects of SLO THEO ES Tablets:\nAs with most medications, SLO THEO ES may cause side effects, although not everyone experiences them. The most commonly reported side effects include:\n\nPalpitations\nNausea or vomiting\nRestlessness or anxiety\nTremors or shakiness\nInsomnia\nHeadache\nIncreased heart rate\n\nGastric discomfort\nSerious but rare side effects can include arrhythmias, severe hypotension, or seizures, especially if used in high doses or in sensitive individuals.\nPrecautions Before Using SLO THEO ES Tablets:\nBefore beginning treatment with SLO THEO ES, it is important to inform your doctor about your medical history, particularly if you have:\n\nHeart disease or high blood pressure\n\nHyperthyroidism\n\nPeptic ulcers\n\nSeizure disorders\n\nLiver or kidney impairment\n\nGlaucoma\n\nDiabetes mellitus\n\nPregnant or breastfeeding women should use SLO THEO ES only under medical supervision. Avoid alcohol or other stimulants that may enhance side effects. Do not exceed the prescribed dosage, and always follow the treatment duration recommended by your physician.\n\nDrug Interactions – What Drugs Interact with SLO THEO ES Tablets?\nSLO THEO ES may interact with several medications, altering their effectiveness or increasing the risk of adverse effects. Inform your healthcare provider if you are taking:\n\nBeta-blockers (e.g., propranolol)\n\nDiuretics (e.g., furosemide)\n\nOral contraceptives\n\nMacrolide antibiotics (e.g., erythromycin)\n\nAntiepileptic drugs (e.g., phenytoin, carbamazepine)\n\nFluoroquinolone antibiotics\n\nCimetidine (a gastric acid reducer)\n\nSteroids or other bronchodilators\n\nAlso, avoid consuming large quantities of caffeine, as both caffeine and theophylline belong to the same chemical class and can increase the risk of overstimulation.\n\nConclusion:\nSLO THEO ES Tablets offer an effective solution for managing obstructive respiratory conditions with its robust combination of etophylline, theophylline, and salbutamol. The synergistic action of these bronchodilators makes it an ideal choice for both acute symptom control and long-term respiratory support. However, due caution should be exercised regarding dosage, potential interactions, and side effects. Always consult your physician before starting or stopping this medication to ensure safe and effective use tailored to your condition.", "price": 95.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2150, "imageuri": "https://productimages.withfloats.com/actual/6880ce15934b5c7d9f2ee4f8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6880ce15934b5c7d9f2ee4f8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-23T11:57:06.443Z", "updatedon": "2026-03-14T08:44:37.478Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//-etophylline-theophylline-and-salbutamol-tablets/2150", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SLO THEO ES TABLETS", "category": "ASTHMARANGE", "tags": [ "Etophylline, Theophylline and Salbutamol Tablets", "chronic obstructive pulmonary disease", "relief from respiratory" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }